Tharimmune, Inc.
THARNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for THAR. That does not mean none is planned.
Get an email about THAR's next catalysts
Track Tharimmune (THAR) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming, 0 past
THAR Reports Financial Results
Filed: 2026-11-16 AccNo: 0001493152-26-052058 Size: 431 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
SourceMarket Overview
Stock performance and key metrics
No drugs found in this phase.
Frequently asked questions
When is Tharimmune, Inc.'s next FDA catalyst?β
CatalystAlert tracks every upcoming catalyst for Tharimmune, Inc. (THAR) β PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β each confidence-rated as confirmed, estimated or AI-detected.
How do I track THAR biotech catalysts?β
Add THAR to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Tharimmune, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β sourced from ClinicalTrials.gov, FDA and SEC filings.
